Similarly, a multiplexed quantitative immunofluorescence analysis in SCLC samples showed significantly lower levels of all TIL markers, MHC class II expression, and CD8+ T cells compared to NSCLC (62). The gene discussed is CD8A; the disease is non-small cell lung carcinoma.